Blood Transfusion Diagnostics Market report focuses on the key player’s profiles in detail with granular analysis of the market share, production technology, market entry strategies, revenue forecasts and regional analysis of the market.
The Global Blood Transfusion Diagnostics Market is expected to rise to valuation of USD 2.45 billion by 2023, rising at a CAGR of 8.2% over its 2016 value of USD 1.5 billion, according to the latest research report from Market Research Future (MRFR). The global blood transfusion diagnostics market is mainly driven by the growing demand for blood transfusions and the growing demand for ensuring safe blood transfusions. The global blood transfusion diagnostics market is assessed in great detail in the report, which provides a thorough review of the market’s key drivers and restraints, leading segments, and major market players.
The global blood transfusion diagnostics market is mainly driven by the growing demand for blood transfusions. The blood transferred during blood transfusions has to be checked for diseases before being transferred to another patient, as bloodborne diseases can be contracted by the recipient. This has led to a growing demand for strong blood transfusion diagnostics infrastructure. In developed regions, the blood transfusion diagnostics infrastructure is widespread and strong due to the high number of blood transfusion procedures carried out in these regions. The receiver of the blood as well as the medical staff are susceptible to diseases contained in donated blood, making it likely that the blood transfusion diagnostics market will grow at a stable growth rate over the forecast period.
The increasing prevalence of infectious diseases and the growing awareness about the need for effective blood transfusion diagnostics are also likely to be major drivers for the global blood transfusion diagnostics market over the forecast period. Infectious diseases are a major concern for the global healthcare sector, making it likely that the global blood transfusion diagnostics market will receive stable government support over the coming years, leading to steady growth of the market.
Industry News:
In June 2019, Dubai Health Authority (DHA) announced the launch of its blood donation campaign, ‘Be the Hero … Save Lives’ for encouraging donators and creating awareness.
In June 2019, The American Chamber of Commerce in Việt Nam (AmCham Vietnam) collaborated with HCM City Institute of Hematology, and Blood Transfusion organized a blood donation campaign to celebrate the World’s Blood Donor Day on 14th of the month.
In February 2019, a two year old in the Tamil Nadu state of India was alleged to have contracted HIV from a blood transfusion. Further enquiries cleared the hospital staff of any wrongdoing, as the source of the HIV was ascertained to be something other than the transfusion. Such incidents reveal the need for strong blood transfusion diagnostics infrastructure, especially in emerging countries.
In January 2019, a leader in transfusion and transplantation diagnostics, Immucor, Inc., has announced that it has received approval from Health Canada for its next-gen fully automated Echo® instrument, Echo LumenaTM.
Key Players for Global Blood Transfusion Diagnostics Market
The prominent players participating in the share assessment of the global blood transfusion diagnostics market are Thermo Fisher Scientific, Inc. (U.S.), Grifols (Spain), Roche Diagnostics (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), BioMérieux (France), Immucor (U.SOrtho Clinical Diagnostics, Inc. (U.S.), ), Becton, Dickinson and Company (U.S.), Siemens Healthineers (Germany), Beckman Coulter, Inc. (U.S.), Novartis AG (Switzerland), Ortho Clinical Diagnostics (U.S), Diagast (France), Abbott Diagnostics (U.S), Beckman Coulter (U.S), BAG healthcare (Germany), Fujirebio (Belgium), DiaSorin (Italy), Grifols (Spain), Hologic/Gen-Probe (U.S), Quidel (U.S), and Biokit (Spain).
Segments for Global Blood Transfusion Diagnostics Market
The global blood transfusion diagnostics market, on the basis of blood product, has been segmented into platelets, red blood cells, plasma, immunoglobulin preparations, albumin, and other products.
Based on technology, the blood transfusion diagnostics market has been segmented into ELISA, nucleic acid amplification, rapid test, western blot, fluorescence assay, and others. The ELISA segment has been sub-segmented into fluorescence immunoassays (FIA), chemiluminescence immunoassay (CLIA), and colorimetric immunoassay (CI). The nucleic acid amplification segment is sub-divided into Thermomechanical analysis (TMA) and real-time PCR.
By end-users, the global blood transfusion diagnostics market has been segmented into clinics, blood banks, hospitals, laboratories.
Regional Analysis for Global Blood Transfusion Diagnostics Market
The global blood transfusion diagnostics market, on the basis of region, has been segmented into four key regions, viz. Europe, Asia Pacific, Americas, and the Middle East and Africa (MEA). Americas is prognosticated to account for the maximum market share in the forthcoming years. The growth can be ascribed to the rising adoption of nucleic acid amplification test. In addition, the increasing count of road accidents is also poised to favor market growth in the region. Europe is in the second spot and is likely to grow significantly over the next couple of years. The rising awareness about blood donation and investments in blood donation campaigns are anticipated to boost revenue generation for the market players. Asia Pacific is also prognosticated to exhibit rapid developments. The exponential population growth of the region is likely to benefit the growth pattern of the blood transfusion diagnostics market.
FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/blood-transfusion-diagnostics-market-1126
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Hadapsar, Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment